195 related articles for article (PubMed ID: 7036973)
1. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Castaldi PA
Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
[TBL] [Abstract][Full Text] [Related]
2. [Present situation of therapy with platelet aggregation inhibitors].
Poliwoda H
Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
[No Abstract] [Full Text] [Related]
3. Aspirin and other platelet-aggregation inhibiting drugs.
Gallus AS
Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and recurrent myocardial infarction.
Jones RJ
JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715
[No Abstract] [Full Text] [Related]
5. Clinical aspects of antiplatelet therapy.
Sherry S
Semin Hematol; 1985 Apr; 22(2):125-34. PubMed ID: 3890191
[No Abstract] [Full Text] [Related]
6. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
7. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Verdecchia P
G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
[No Abstract] [Full Text] [Related]
8. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Hirsh J
Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
[TBL] [Abstract][Full Text] [Related]
9. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents: rationale and results.
Kelton JG
Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
[No Abstract] [Full Text] [Related]
11. Prevention of death from myocardial infarction by aspirin and other platelet active drugs.
Elwood PC
Clin Cardiol; 1979 Aug; 2(4):241-5. PubMed ID: 400517
[No Abstract] [Full Text] [Related]
12. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
13. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
14. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Turpie AG
Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
[TBL] [Abstract][Full Text] [Related]
15. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Polli EE; Cortellaro M
Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
[No Abstract] [Full Text] [Related]
16. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev SV
Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
[No Abstract] [Full Text] [Related]
17. [Mode of action and clinical evaluation of platelet aggregation inhibitors].
David JL
Rev Med Liege; 1987 May; 42(10):526-33. PubMed ID: 3616303
[No Abstract] [Full Text] [Related]
18. [Prophylactic value of platelet anti-aggregants in coronary disease].
Verstraete M
Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
[No Abstract] [Full Text] [Related]
19. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Klimt CR; Doub PH; Doub NH
Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
de Gaetano G; Cerletti C; Bertelè V
Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
